Hemostasis Analyzers Market Statistics Report 2028

Hemostasis Analyzers Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type [Laboratory Analyzer (Automated Systems, Semi-Automated Systems, and Manual Systems) and Point-of-Care Testing Systems], Test [Activated Partial Thromboplastin Time, D-Dimer Test, Fibrinogen Test, Prothrombin Time (PT) Test, and Others], and End User (Hospitals/Clinics, Independent Diagnostic Laboratories, Home Care Setting, and Others)

  • Report Code : TIPRE00016709
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 188
Buy Now

The hemostasis analyzers market is projected to reach US$ 6,490.24 million by 2028 from US$ 3,440.66 million in 2021; it is expected to register a CAGR of 9.5% from 2021 to 2028.

Hemostasis analyzers provide a quick and easy measurement of blood platelet levels. A coagulation test could help detect and prevent blood clots that could cause a heart attack. A coagulation analyzer can measure the speed of the coagulation pathway and the amounts of thrombolin and thromboplastin in less than a few minutes.Cardiovascular diseases (CVDs) are likely to remain the most significant cause of morbidity and mortality worldwide. The CVDs are disorders of the heart and blood vessels and include cerebrovascular disease, coronary heart disease, rheumatic heart disease, and other conditions. Some lifestyle-related issues that lead to cardiovascular diseases and difficulties are tobacco use, unhealthy diet, and physical inactivity. They increase the risk of heart attacks and strokes. Other risk factors for cardiovascular diseases are high blood pressure, diabetes, and increased cholesterol levels. According to the World Health Organization (WHO), cardiovascular diseases are the number one cause of death globally.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Hemostasis Analyzers Market: Strategic Insights

hemostasis-analyzers-market
Market Size Value inUS$ 3,440.66 million in 2021
Market Size Value byUS$ 6,490.24 million by 2028
Growth rateCAGR of 9.5% from 2021 to 2028.
Forecast Period2021-2028
Base Year2021
Analyst Image

Akshay

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

Lucrative Regions for Hemostasis Analyzers Market

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Market Insights
Rise in Geriatric Population to Drive Hemostasis Analyzers Market

Older people are prone to heart diseases due to weak immunity and other health problems. General aging factors lead to stiffening heart and blood vessels that result in heart disorders. As the age grows, the systolic blood pressure also rises, leading to cardiovascular diseases (CVDs). Thus, in people aged 75 years and above, high blood pressure is a common risk factor for heart conditions. Coronary artery disease and heart failure are the others. Although the incidence of arrhythmias encompasses people of all age groups, it is rising significantly among the geriatric population.

According to the Global Ageing 2019 survey, the world's population of 65 years and above totaled 703 million in 2019. The senior demographic is expected to double to 1.5 billion people by 2050. The frequency of one person with age 65 or more is likely to increase from 1 in every 11 inhabitants in 2019 to 1 in every 6 inhabitants by 2025. This demographic is more susceptible to CVDs, such as arrhythmias. Similarly, according to the World Health Organization (WHO), the percentage of people aged 60 and above is estimated to reach 22% by 2050 from 12% in 2015. As per the report "Older Americans 2016: Key Indicators of Well-Being" by the Federal Interagency Forum on Aging-Related Statistics, 35.8% of individuals aged 85 and above had a mild or extreme cognitive disorder. Moreover, according to the United Nation's World Population Ageing 2017 report, in 2017, 962 million people were aged 60 years or over worldwide, and the number is expected to reach nearly 2.1 billion by 2050.

The elderly population is more prone to atypical presentations, comorbid conditions, and unfavorable outcomes. The primary reason for the diseases is related to the structural and functional changes in the cardiovascular system associated with aging. The rise in the global geriatric population is leading to a surge in cardiovascular diseases, which, in turn, is propelling the demand for hemostasis analyzers



Product Type-Based Insights

Based on product type, the hemostasis analyzers market is further segmented into laboratory analyzers and point-of-care testing systems. In 2021, the laboratory analyzers segment is held the largest share of the market, and the point-of-care testing systems segment is estimated to register the highest CAGR during 2021–2028.

Hemostasis Analyzers Market Share, by Product Type – 2021 and 2028


medical-device
Hemostasis Analyzers Market Share, by Product Type – 2021 and 2028
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Test-Based Insights

Based on test, the market is segmented into activated partial thromboplastin time, D-Dimer test, fibrinogen test, prothrombin time test, and others. In 2021, the activated partial thromboplastin time segment held the largest share of the market. The prothrombin time test segment is expected to register the highest CAGR in the market during 2021–2028.

End User-Based Insights

Based on end users, the market is segmented into hospitals/clinics, independent diagnostic laboratories, home care settings, and others. In 2021, the hospitals/clinics segment accounted for the largest share of the market. The independent diagnostic laboratories segment is expected to register the highest CAGR in the market during 2021–2028.

Companies operating in the hemostasis analyzers market emphasize adopting the strategy of product innovations to meet the evolving customer demands worldwide, which also permits them to maintain their brand name in the global market.

Hemostasis Analyzers Market – Segmentation

The Hemostasis Analyzers market is segmented based on product type, test, and end-user. Based on product type, the hemostasis analyzers market is segmented into laboratory analyzers and point-of-care testing systems. Based on test, the market is further segmented into activated partial thromboplastin time, D-Dimer test, fibrinogen test, prothrombin time test, and others. Based on end-user, the market is segmented into hospitals/clinics, independent diagnostic laboratories, home care settings, and others. In terms of geography, the hemostasis analyzers market is segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, Italy, the UK, Spain, and the Rest of Europe), Asia Pacific (Australia, China, India, Japan, South Korea, and the Rest of APAC), the Middle East & Africa (Saudi Arabia, South Africa, the UAE, and the Rest of MEA), and South and Central America (Brazil, Argentina, and the Rest of SCAM)

Company Profiles

  • Siemens AG
  • Instrumentation Laboratory
  • Abbott
  • Sysmex Corporation
  • Nihon Kohden Corporation
  • Thermo Fisher Scientific Inc.
  • Roche Diagnostics
  • Diagnostica Stago
  • Helena Laboratories
  • International Technidyne Corporation.
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Product Type, Test, and End User

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States

Frequently Asked Questions


What is hemostasis analyzers?

Hemostasis analyzers are medical devices that are used to measure the clotting time of hemostasis to detect clotting deficiencies and facilitate the treatment of patients with an excess bleeding condition by medical practitioners.

What are the factors impacting the Hemostasis Analyzers market?

The factors driving and restraining the hemostasis analyzers market in the coming years include the high prevalence of cardiovascular diseases and the rise in the geriatric population. However, the high cost of a fully automated hemostasis analyzer is likely to hamper the market's growth.

Who are the major players in the hemostasis analyzers market?

The hemostasis analyzers market majorly consists of the players such as Siemens AG, Instrumentation Laboratory, Abbott, Sysmex Corporation, Nihon Kohden Corporation, Thermo Fisher Scientific Inc., Roche Diagnostics, Diagnostica Stago, Helena Laboratories, International Technidyne Corporation are amongst others.

What is the market value of the hemostasis analyzers market based on region?

The global hemostasis analyzers market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. In the North America region, the market for hemostasis analyzers market is primarily held by the US among the other countries. The growth of the hemostasis analyzers market in the United States is expected to grow owing to increasing organic developments by the market players in the market, rising awareness among consumers for treatment, and an increase in the prevalence of chronic illnesses like blood disorders and cardiovascular diseases.

Which is the most influencing segment growing in the hemostasis analyzers market report?

The global hemostasis analyzers market based on product is segmented into product type [laboratory analyzer (automated systems, semi-automated systems, and manual systems) and point-of-care testing systems. In 2021, the laboratory analyzer segment held the largest share of the market by product and point-of-care testing systems is expected to witness the fastest CAGR during 2021 to 2028.

Which region is expected to witness significant demand for the hemostasis analyzers market in the coming years?

The Asia Pacific is expected to be the fastest-growing region and is likely to expand at a high growth rate due to the rising development in the pharmaceutical sector. Also, the rise in the incidence of cardiovascular diseases is likely to provide more significant growth opportunities to the market players in the coming years is likely to boost the growth of the market in the Asia Pacific region.

The List of Companies - Hemostasis Analyzers Market

  1. Siemens AG
  2. Instrumentation Laboratory
  3. Abbott
  4. Sysmex Corporation
  5. Nihon Kohden Corporation
  6. Thermo Fisher Scientific Inc.
  7. Roche Diagnostics
  8. Diagnostica Stago
  9. Helena Laboratories
  10. International Technidyne Corporation

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Hemostasis Analyzers Market